Genzyme Receives Innovation Award from the National Organization for Rare Disorders (NORD) for the Development of Cerdelga®
22-May-2015 -
Genzyme, a Sanofi company, announced that it has received the 2015 Industry Innovation Award from the National Organization for Rare Disorders (NORD) in recognition of Cerdelga® (eliglustat) capsules. Genzyme was selected for the company’s work in bringing an additional treatment option to ...
eliglustat
Gaucher disease
Genzyme